Price Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-26,298
Closed -$1.63M 10
2018
Q3
$1.63M Buy
+26,298
New +$1.56M 0.58% 8
2015
Q2
Sell
-3,400
Closed -$219K 31
2015
Q1
$219K Buy
+3,400
New +$213K 0.14% 281

Other funds holding BMY

Price Capital Management's BMY Position: Q4 2018 in Review

Price Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 26,298 shares — an estimated $1.63M sold.

Price Capital Management first reported a position in BMY in Q1 2015 and held it in 2 quarters. The position peaked at $1.63M in Q3 2018. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • Price Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
  • Price Capital Management sold 26,298 Bristol-Myers Squibb shares in Q4 2018, an estimated $1.63M.
  • Price Capital Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 2 quarters.
  • Price Capital Management's Bristol-Myers Squibb position peaked at $1.63M in Q3 2018.
  • 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Price Capital Management's 13F filing for Q4 2018, filed 15 Jan 2019.